Rocket Lab USA Inc (NASDAQ: RKLB) Loses -49.32% From High. Why That Could Change?

Currently, there are 488.92M common shares owned by the public and among those 283.93M shares have been available to trade.

The company’s stock has a 5-day price change of 0.74% and -29.53% over the past three months. RKLB shares are trading -26.22% year to date (YTD), with the 12-month market performance up to 3.03% higher. It has a 12-month low price of $3.62 and touched a high of $8.05 over the same period. RKLB has an average intraday trading volume of 8.74 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.29%, -8.82%, and -20.30% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of Rocket Lab USA Inc (NASDAQ: RKLB) shares accounts for 26.09% of the company’s 488.92M shares outstanding.

It has a market capitalization of $2.00B and a beta (3y monthly) value of 1.18. The earnings-per-share (ttm) stands at -$0.38. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.08% over the week and 4.13% over the month.

Analysts forecast that Rocket Lab USA Inc (RKLB) will achieve an EPS of -$0.11 for the current quarter, -$0.1 for the next quarter and -$0.14 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.11 while analysts give the company a high EPS estimate of -$0.1. Comparatively, EPS for the current quarter was -$0.1 a year ago. Earnings per share for the fiscal year are expected to decrease by -36.37%, and 74.98% over the next financial year.

Looking at the support for the RKLB, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on February 12, 2024, with the firm’s price target at $6. KeyBanc Capital Markets coverage for the Rocket Lab USA Inc (RKLB) stock in a research note released on January 17, 2024 offered a Overweight rating with a price target of $8. Cantor Fitzgerald was of a view on October 26, 2023 that the stock is Overweight, while Citigroup gave the stock Neutral rating on April 18, 2023, issuing a price target of $4.55. Credit Suisse on their part issued Underperform rating on October 12, 2022.

Most Popular

Related Posts